Method for the determination of the levels of β-amyloid peptide in the CSF sampled from freely moving rats-Reference-Cited by-同舟云学术

Method for the determination of the levels of β-amyloid peptide in the CSF sampled from freely moving rats

Published:2005-09 Issue:2 Volume:52 Page:229-233
ISSN:1056-8719
Container-title:Journal of Pharmacological and Toxicological Methods
language:en
Short-container-title:Journal of Pharmacological and Toxicological Methods

Author:

El Mouedden Mohammed,Haseldonckx Marc,Mackie Claire,Meert Theo,Mercken Marc

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference33 articles.

1. The genetics of Alzheimer disease: Current status and future prospects;Blacker;Archives of Neurology,1998

2. A rapid and simple cannulation technique for repeated sampling of cerebrospinal fluid in freely moving rats;Bouman;Brain Research Bulletin,1979

3. A kenetic analyses of 5-hydroxyindole-acetic acid excretion from rat brain and CSF;Burns;Biological Psychiatry,1976

4. Effect of heparin or salicylate infusion on serum protein binding and on concentrations of phenytoin in serum and cerebrospinal fluid of rats;Chou;Journal of Pharmacology and Experimental Therapeutics,1981

5. Physiology of the cerebrospinal fluid;Davson,1967

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of the Metabotropic Glutamate Receptor Type 5 Negative Allosteric Modulator Dipraglurant on Motor and Non-Motor Symptoms of Parkinson’s Disease;Cells;2023-03-24

2. Refinement of a model of repeated cerebrospinal fluid collection in conscious rats;Laboratory Animals;2016-07-10

3. β-Secretase (BACE1) Inhibitors with High in Vivo Efficacy Suitable for Clinical Evaluation in Alzheimer’s Disease;Journal of Medicinal Chemistry;2013-05-02

4. A Potent and Selective Metabotropic Glutamate Receptor 4 Positive Allosteric Modulator Improves Movement in Rodent Models of Parkinson's Disease;Journal of Pharmacology and Experimental Therapeutics;2012-07-11

5. The dynamics of Aβ distribution after γ-secretase inhibitor treatment, as determined by experimental and modelling approaches in a wild type rat;Journal of Pharmacokinetics and Pharmacodynamics;2012-04-06